Puma Biotechnology, Inc.'s (NASDAQ:PBYI) US$24m market value fall may be overlooked by institutional investors after a year of 1.6% returns - Simply Wall St News
Puma Biotechnology
Puma Biotech (PBYI) Up More Than 95% in 3 Months: Here's Why
Is Puma off the cancer M&A list? With Nerlyx marketing deal, some investors think so | Fierce Pharma
PBYI Stock Price and Chart — NASDAQ:PBYI — TradingView
Puma Biotechnology (NASDAQ:PBYI) Stock Price News
Puma Biotechnology | $PBYI Stock | Shares Climb Up as Company Announced FDA Approval for NERLYNX - Warrior Trading News